OOIR: Observatory of International Research

Papers

(The H4-Index of Transplantation is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
T-cell Immunometabolism: Therapeutic Implications in Organ Transplantation	144
The Challenges of Risk Aversion in Kidney Transplantation: Lessons From the SARS-CoV-2 Pandemic in Brazil	144
Research Highlights	107
Variations in Swine Liver Anatomy	105
Outcomes of Coccidioides Seropositive Solid Organ Transplant Recipients After Self-discontinuation of Antifungal Prophylaxis: The EIA-IgM-only Conundrum	87
Coronary Computed Tomography Angiography in Heart Transplant Patients: Current Insights and Future Directions	86
Ethical Considerations in Nonconsenting Adult Allogeneic Stem Cell Donors	84
The Presence of Donor-specific Antibodies Around the Time of Pancreas Graft Biopsy With Rejection Is Associated With an Increased Risk of Graft Failure	79
BAASIS for Monitoring Therapy Nonadherence in Clinical Transplantation: Are We There Yet?	74
The Case for Prolonged ECMO for COVID-19 ARDS as a Bridge to Recovery or Lung Transplantation	71
Report of the Standardized Outcomes in Nephrology-transplant Consensus Workshop on Establishing a Core Outcome Measure for Infection in Kidney Transplant Recipients	66
Dr Andreas Gerasimos Tzakis, MD, PhD, Dhc (mult), Professor of Surgery, Emeritus Director of Transplantation, Cleveland Clinic	63
Distinct Outcomes of Kidney Transplant Recipients With Recent COVID-19 According to the Timing of Infection	63
Inactivating the Innate Immune Receptor CD11b With a First-in-Class Monoclonal Antibody Prolongs the Survival of Kidney Allografts in Nonhuman Primates	61
Solid Organ Transplantation From Deceased Donors With Infective Endocarditis: The UK Experience	61
76: Non-vascularized Abdominal Rectus Fascia for abdominal closure after transplantation, single center report and long-term follow-up	60
46: The fall of a myth: the first three cases of DCD in intestinal transplantation	58
O-46: Cost-utility of Kitelock in Preventing Central Line-associated Blood Stream Infections in Children with Intestinal Failure: A Markov Model	53
P-17: Transplant Associated Thrombotic Microangiopathy and Immune Haematological Complications Following Intestine Containing Organ Transplantation: Experience from Over 100 Consecutive Cases	53
P-19: Intestinal Failure Associated Liver Disease in Paediatric Patients Underwent Intestinal Lengthening Surgery for Short Bowel Syndrome	52
PE-23: Reversal of Treatment-refractory Malabsorption after Resection of Jejunal Diverticulosis: A Case Series	50
PE-17: Blockage of PD-L1 Expression in Intestinal Graft Accelerates Allogeneic Immune Response in Mice	49
P-38: Use of Lactase Enzyme for Control of Diarrhea in Patients Breast Fed with Short Bowel Syndrome	48
P-85: Quality of Life in Patients in Home Parenteral Nutrition in Brazil	47
P-94: The Need for Social Care Support in Children Pre- and Post-Intestiinal Transplant, A Case Series	47

P-27: Results of Ernica* Survey on Food Introduction in Infants with Short Bowel Syndrome Managed by Specialist Intestinal Failure Rehabilitation Centres	47
PE-20: Development of a Consensus Parenteral Nutrition Weaning Algorithm for Paediatric Patients with Short-bowel Syndrome Responding to Teduglutide Therapy	46
O-05: Ghrelin in Children with Intestinal Failure Receiving Long-term Parenteral Nutrition	44
P-51: Successful Central Venous Catheter Salvage after Central Line Associated Blood Stream Infections(CLABSI) in Children on Long-term Home Parenteral Nutrition(PN)	43
*O-30: Stoma-output Reinfusion Device for Ileostomy Patients: A Feasibility Study	42
PE-1: “Line Care Governs Our World”: Understanding the Lived Experience of Caregivers of Children with Intestinal Failure on Long-term Parenteral Nutrition	42
P-39: Health Care Costs Associated with Australian Home Parenteral Nutrition	41
P-60: Single Centre Experience of Paediatric Intestinal Transplantation During the COVID-19 Pandemic: Lessons from Adapting to Pandemic Pressures	41
PE-21: Assessment of Moderate and Severe Intestinal Failure Associated Liver Disease. Clinical, Analytical and Histological Correlation	39
PE-12: Role of B-cell Subsets in Allograft Rejection in Intestinal Transplantation	39
O-49: The First Five Years of the New Zealand National Intestinal Failure & Rehabilitation Service	37
O-14: Portal Hypertensive Complications after Pediatric Combined Liver-intestine Transplantation from Late Vascular Compromise of Native Portacaval Shunt: Clinical Presentation and Management	37
P-66: Adequate Exposure to Tacrolimus with Sublingual Administration	37